Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
5
×
san francisco blog main
biotech
fda
new york blog main
san francisco top stories
boston blog main
deals
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
auris health
biogen
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
intuitive surgical
ipo
johnson & johnson
roboticsai
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
abbvie
What
plans
5
×
cash
company
deal
ipo
medical
acquiring
acquisitions
administration
advance
angry
announced
anti
auris
benefited
billion
bio
biology
builds
buy
ceo
clearance
collabs
company’s
covid
crunch
cytokine
daniel
despite
developer
didn’t
drug
drugs
end
enhanced
fda
fear
files
gilead
gilead’s
Language
unset
Current search:
plans
×
" national top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs